Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases.

Volk, Andreas M

Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases. [electronic resource] - BMC cancer Feb 2016 - 84 p. digital

Publication Type: Journal Article; Meta-Analysis

1471-2407

10.1186/s12885-016-2095-6 doi


Bevacizumab--administration & dosage
Camptothecin--administration & dosage
Colorectal Neoplasms--drug therapy
Fluorouracil--administration & dosage
Hepatectomy
Hepatic Veno-Occlusive Disease--drug therapy
Humans
Liver--drug effects
Liver Neoplasms--drug therapy
Neoadjuvant Therapy--adverse effects